Farid Rahimi

2.7k total citations
50 papers, 1.8k citations indexed

About

Farid Rahimi is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Farid Rahimi has authored 50 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Physiology and 10 papers in Infectious Diseases. Recurrent topics in Farid Rahimi's work include Alzheimer's disease research and treatments (14 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and S100 Proteins and Annexins (7 papers). Farid Rahimi is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and S100 Proteins and Annexins (7 papers). Farid Rahimi collaborates with scholars based in Australia, Iran and United States. Farid Rahimi's co-authors include Gal Bitan, Carolyn L. Geczy, Angelika Bröer, Stefan Bröer, Claire E. Shepherd, Glenda M. Halliday, Amin Talebi Bezmin Abadi, Kenneth Hsu, Jesse Goyette and Anna Sokolova and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Farid Rahimi

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farid Rahimi Australia 21 1.0k 524 314 249 186 50 1.8k
Weihong Zhou China 26 1.2k 1.1× 282 0.5× 434 1.4× 213 0.9× 133 0.7× 76 2.5k
Paola Borgiani Italy 31 846 0.8× 300 0.6× 556 1.8× 356 1.4× 49 0.3× 137 2.6k
Van Hung Nguyen Vietnam 18 1.2k 1.2× 123 0.2× 129 0.4× 271 1.1× 108 0.6× 68 3.8k
Ephrem Tekle United States 20 1.8k 1.7× 286 0.5× 400 1.3× 193 0.8× 38 0.2× 32 2.7k
Dohyun Han South Korea 24 1.4k 1.3× 325 0.6× 215 0.7× 227 0.9× 99 0.5× 130 2.3k
Angela Alexander United States 22 1.4k 1.4× 200 0.4× 295 0.9× 293 1.2× 53 0.3× 55 2.6k
Hatem Zayed Qatar 32 2.0k 1.9× 340 0.6× 265 0.8× 383 1.5× 35 0.2× 175 3.3k
Delvac Oceandy United Kingdom 31 1.5k 1.5× 273 0.5× 526 1.7× 141 0.6× 157 0.8× 92 2.9k
David Masson France 38 1.2k 1.2× 320 0.6× 873 2.8× 423 1.7× 59 0.3× 162 4.5k
Mark S. Williams United States 29 1.6k 1.6× 289 0.6× 1.4k 4.5× 395 1.6× 168 0.9× 82 3.3k

Countries citing papers authored by Farid Rahimi

Since Specialization
Citations

This map shows the geographic impact of Farid Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farid Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farid Rahimi more than expected).

Fields of papers citing papers by Farid Rahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farid Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farid Rahimi. The network helps show where Farid Rahimi may publish in the future.

Co-authorship network of co-authors of Farid Rahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Farid Rahimi. A scholar is included among the top collaborators of Farid Rahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farid Rahimi. Farid Rahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahimi, Farid, et al.. (2025). Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori. BMC Research Notes. 18(1). 109–109. 2 indexed citations
2.
Rahimi, Farid & Amin Talebi Bezmin Abadi. (2024). ChatGPT and Corporations of Mega-journals Jeopardize the Norms That Underpin Academic Publishing. Archives of Iranian Medicine. 27(2). 110–112.
3.
Abadi, Amin Talebi Bezmin, et al.. (2022). Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer. BMC Research Notes. 15(1). 316–316. 1 indexed citations
4.
Rahimi, Farid & Amin Talebi Bezmin Abadi. (2022). Is Omicron the last SARS-CoV-2 Variant of Concern?. Archives of Medical Research. 53(3). 336–338. 10 indexed citations
5.
6.
Taghvaei, Tarang, et al.. (2021). Isolation of dupA-positive and clarithromycin-resistant Helicobacter pylori from Iranian patients with duodenal ulcer. Gene Reports. 24. 101228–101228. 2 indexed citations
7.
Rahimi, Farid, et al.. (2021). Emergence of the Delta Plus variant of SARS-CoV-2 in Iran. Gene Reports. 25. 101341–101341. 13 indexed citations
8.
Rahimi, Farid & Amin Talebi Bezmin Abadi. (2020). Challenges of managing the asymptomatic carriers of SARS-CoV-2. Travel Medicine and Infectious Disease. 37. 101677–101677. 26 indexed citations
9.
Abadi, Amin Talebi Bezmin, et al.. (2020). Plagiarism, Fake Peer-Review, and Duplication: Predominant Reasons Underlying Retractions of Iran-Affiliated Scientific Papers. Science and Engineering Ethics. 26(6). 3455–3463. 15 indexed citations
10.
Abadi, Amin Talebi Bezmin, et al.. (2020). FadA-positive Fusobacterium nucleatum is prevalent in biopsy specimens of Iranian patients with colorectal cancer. New Microbes and New Infections. 34. 100651–100651. 22 indexed citations
11.
Rahimi, Farid, et al.. (2020). Tackling the COVID-19 Pandemic. Archives of Medical Research. 51(5). 468–470. 17 indexed citations
12.
Rahimi, Farid, et al.. (2020). Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat. Archives of Medical Research. 51(3). 280–281. 23 indexed citations
13.
Abadi, Amin Talebi Bezmin, et al.. (2019). Helicobacter heilmannii Colonization Is Associated with High Risk for Gastritis. Archives of Medical Research. 50(7). 423–427. 10 indexed citations
14.
Attar, Aida, Farid Rahimi, & Gal Bitan. (2013). Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01. Translational Neuroscience. 4(4). 385–409. 20 indexed citations
15.
Solomonov, Inna, Eduard Korkotian, Benjamin Born, et al.. (2012). Zn2+-Aβ40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons. Journal of Biological Chemistry. 287(24). 20555–20564. 36 indexed citations
16.
Rahimi, Farid & Gal Bitan. (2010). Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease. Journal of Visualized Experiments. 23 indexed citations
17.
Goyette, Jesse, Wei Yan, Su Yin Lim, et al.. (2009). Pleiotropic Roles of S100A12 in Coronary Atherosclerotic Plaque Formation and Rupture. The Journal of Immunology. 183(1). 593–603. 63 indexed citations
18.
Rahimi, Farid, et al.. (2009). RNA Aptamers Generated against Oligomeric Aβ40 Recognize Common Amyloid Aptatopes with Low Specificity but High Sensitivity. PLoS ONE. 4(11). e7694–e7694. 56 indexed citations
19.
Rahimi, Farid, et al.. (2008). Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders. Current Alzheimer Research. 5(3). 319–341. 77 indexed citations
20.
Hsu, Kenneth, Robert Passey, Yasumi Endoh, et al.. (2005). Regulation of S100A8 by Glucocorticoids. The Journal of Immunology. 174(4). 2318–2326. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weihong Zhou Breakdown of academic impact, for papers by Paola Borgiani Breakdown of academic impact, for papers by Van Hung Nguyen Breakdown of academic impact, for papers by Ephrem Tekle Breakdown of academic impact, for papers by Dohyun Han Breakdown of academic impact, for papers by Angela Alexander Breakdown of academic impact, for papers by Hatem Zayed Breakdown of academic impact, for papers by Delvac Oceandy Breakdown of academic impact, for papers by David Masson Breakdown of academic impact, for papers by Mark S. Williams
Rankless by CCL
2026